Revue des Maladies Respiratoires. 2008 Oct;25(8 Pt 2):3S191-5. [Link]
DÃ©partement des Soins Intensifs et Oncologie Thoracique, Institut Jules-Bordet (Centre des Tumeurs de l’UniversitÃ© Libre de Bruxelles), 1 Rue HÃ©ger-Bordet, Brussels, Belgium. firstname.lastname@example.org
Malignant pleural mesothelioma is a rare tumour of poor prognosis. Available therapeutics have restricted efficacy. Pleuro-pneumonectomy is the only treatment with curative intent but it could be offered to a limited and well selected group of patients. The role of radiotherapy is palliative and its preventive role on malignant seeding after invasive procedures is controversial. There are few active cytotoxic drugs in this disease. Currently, based on two randomised trials, the most efficacious chemotherapy regimen consists in a combination of cisplatin and an antifolate agent, pemetrexed or raltitrexed.
Keywords: Mesothelioma, Surgery, Radiotherapy, Chemotherapy